420627008: Extended-release tablet (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

2616687018 Extended-release tablet en Synonym Active Entire term case insensitive SNOMED CT core module

2660656013 Extended-release tablet (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Extended-release tablet	Is a	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Prolonged-release film-coated oral tablet	Is a	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Gastro-resistant and prolonged-release oral tablet	Is a	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely paliperidone 9 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely paliperidone 6 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely paliperidone 3 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Amoxicillin 775mg extended release tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each prolonged-release oral tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 200 milligram/1 each prolonged-release oral tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely bupropion hydrobromide 348 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Guanfacine hydrochloride 4mg extended release tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Guanfacine hydrochloride 3mg extended release tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Guanfacine hydrochloride 1mg extended release tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely nicotinic acid 250 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely ropinirole (as ropinirole hydrochloride) 8 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Guanfacine hydrochloride 2mg extended release tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Ropinirole 3mg extended release tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely potassium chloride 1.5 gram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pramipexole dihydrochloride 375 microgram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pramipexole dihydrochloride 750 microgram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pramipexole dihydrochloride 1.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely trazodone hydrochloride 150 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pramipexole dihydrochloride 4.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely nevirapine 400 milligram/1 each prolonged-release oral tablet	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seroquel XL 200mg tablets (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seroquel XL 300mg tablets (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seroquel XL 400mg tablets (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seroquel XL 200mg tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seroquel XL 300mg tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seroquel XL 400mg tablets (Doncaster Pharmaceuticals Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Viramune 400mg modified-release tablets (Boehringer Ingelheim Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Sondate XL 200mg tablets (Teva UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Sondate XL 300mg tablets (Teva UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Sondate XL 400mg tablets (Teva UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Tenprolide XL 200mg tablets (Actavis UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Tenprolide XL 300mg tablets (Actavis UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seotiapim XL 200mg tablets (Sandoz Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seotiapim XL 400mg tablets (Sandoz Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Seotiapim XL 300mg tablets (Sandoz Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Tenprolide XL 400mg tablets (Actavis UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Ebesque XL 200mg tablets (DB Ashbourne Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Ebesque XL 300mg tablets (DB Ashbourne Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Ebesque XL 400mg tablets (DB Ashbourne Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Atrolak XL 200mg tablets (Accord Healthcare Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Atrolak XL 300mg tablets (Accord Healthcare Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Atrolak XL 400mg tablets (Accord Healthcare Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Biquelle XL 300mg tablets (Aspire Pharma Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Biquelle XL 400mg tablets (Aspire Pharma Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Biquelle XL 200mg tablets (Aspire Pharma Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Zaluron XL 200mg tablets (Fontus Health Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Zaluron XL 300mg tablets (Fontus Health Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Zaluron XL 400mg tablets (Fontus Health Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Mintreleq XL 200mg tablets (CEB Pharma Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Mintreleq XL 300mg tablets (CEB Pharma Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Mintreleq XL 400mg tablets (CEB Pharma Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Psyquet XL 200mg tablets (Sandoz Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Psyquet XL 300mg tablets (Sandoz Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Psyquet XL 400mg tablets (Sandoz Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Nevirapine 400mg modified-release tablets (Teva UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Nevirapine 400mg modified-release tablets (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Brancico XL 300mg tablets (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Brancico XL 200mg tablets (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Brancico XL 400mg tablets (Zentiva Pharma UK Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier
Nevirapine 400mg modified-release tablets (Viatris UK Healthcare Ltd)	Has manufactured dose form	False	Extended-release tablet	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2616687018	Extended-release tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
2660656013	Extended-release tablet (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module